Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPC-15007046Phase 4Completed
Phase 4, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Tangshan Gongren Hospital. Primary endpoints: symptomatic intracranial hemorrhage, 90-day mortality and 2 more. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPC-15007046.